References
- Smolen JS, Landewe R, Bijlsma J, et al. EULAR recommendation for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–977.
- Eguchi K, Matsuoka N, Ida H, et al. Primary Sjögren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis. 1992;51:769–776.
- Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren’s syndrome. Lancet. 1994;344:1116–1119.
- Eguchi K, Origuchi T, Takashima H, et al. High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis. Arthritis Rheum. 1996;39:463–466.
- Hida A, Imaizumi M, Sera N, et al. Association of human T lymphotropic virus type I with Sjogren syndrome. Ann Rheum Dis. 2010;69:2056–2067.
- Kawakami A, Eguchi K. Role of HTLV-I infection in the pathogenesis of Sjögren’s syndrome and rheumatoid arthritis. Mod Rheumatol. 2001;11:87–90.
- Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–335.
- Nakamura H, Ueki Y, Saito S, et al. Development of adult T-cell leukemia in a patient with rheumatoid arthritis treated with tocilizumab. Intern Med. 2013;52:1983–1986.
- Iwanaga M, Watanabe T, Utsunomiya A, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood. 2010;116:1211–1219.
- Matsuzaki T, Eguchi K, Nagao N, et al. Hepatitis B virus reactivation in patients with rheumatoid arthritis: a single-center study. Mod Rheumatol. 2018;28:808–813.
- Nosaka K, Iwanaga M, Imaizumi Y, et al. Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010–2011: a nationwide survey. Cancer Sci. 2017;108:2478–2486.
- Shimamoto Y, Nomura S, Ishii K, et al. Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus. Int J Hematol. 2009;89:128–129.
- Bittencourt AL, Oliveira PD, Bittencourt VG, et al. Adult T-cell leukemia/lymphoma triggered by adalimumab. J Clin Virol. 2013;58:494–496.
- Dasanu CA, Bauer F, Ichim TE, et al. Rapidly fetal acute ATLL emerging after methotrexate therapy for disseminated psoriasis. Clin Lymphoma Myeloma Leuk. 2012;12:76–78.
- Adams AE, Zwicker J, Curiel C, et al. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol. 2004;51:660–662.
- Terada Y, Kamoi K, Ohno-Matsui K, et al. Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: a case report. Medicine (Baltimore). 2017;96:e6021.
- Nakamura N, Tamaru S, Ohshima K, et al. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc. 2005;37:1779–1782.
- Kawano N, Shimoda K, Ishikawa F, et al. Adult T-cell leukemia development from a human T-cell leukemia virus type 1 carrier after living – donor liver transplantation. Transplantation. 2006;82:840–843.
- Yakova M, Lezin A, Dantin F, et al. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease. Retrovirology. 2005;2:4.
- Taylor GP, Tosswill JHC, Matutes E, et al. Prospective study of HTLV-1 infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999;22:92–100.
- Kimura I, Tsubota T, Tada S, et al. Presence of antibodies against adult T cell leukemia antigen in the patients with chronic respiratory diseases. Acta Med Okayama. 1986;40:281–284.
- Suzuki T, Fukui S, Umekita K, et al. Attenuated effectiveness of tumor necrosis inhibitors for anti-human T lymphotropic virus type 1 antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2018;8:1014–1021.